Duration of action of topical antiallergy drugs in a guinea pig model of histamine-induced conjunctival vascular permeability

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 4, 2007, Pages 315-320

  Beauregard, Clay ^a   Stephens, Donna ^a   Roberts, Leighann ^a   Gamache, Daniel ^a   Yanni, John ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; AZELASTINE; EPINASTINE; HISTAMINE; KETOTIFEN FUMARATE; OLOPATADINE; DIBENZAZEPINE DERIVATIVE; DIBENZOXEPIN DERIVATIVE; EYE DROPS; HISTAMINE H1 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; KETOTIFEN; PHTHALAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONJUNCTIVA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; GUINEA PIG; MALE; NONHUMAN; ANIMAL; CAPILLARY PERMEABILITY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DRUG EFFECT; METABOLISM; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-ALLERGIC AGENTS; CAPILLARY PERMEABILITY; CONJUNCTIVA; DELAYED-ACTION PREPARATIONS; DIBENZAZEPINES; DIBENZOXEPINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; IMIDAZOLES; KETOTIFEN; MALE; OPHTHALMIC SOLUTIONS; PHTHALAZINES;

EID: 35848937145     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.0138     Document Type: Article

References (10)

1. Yanni, J.M., L.K. Weimer, N.A. Sharif, S.X. Xu, D.A. Gamache, and J.M. Spellman. 1999. Inhibition of Histamine-induced Human Conjunctival Epithelial Cell Responses by Ocular Allergy Drugs. Arch Ophthalmol 117:643.
2. Ohshima, E., S. Otaki, H. Sato, T. Kumazawa, H. Obase, A. Ishii, K. Ohmori, and N. Hirayama. 1992. Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives. J Med Chem 35:2074.
3. Berdy, G.J., M.B. Abelson, M.A. George, L.M. Smith, and R.L. Giovanoni. 1996. Allergic conjunctivitis: a survey of new antihistamines. J Ocular Pharmacol Ther 7:313.
4. Yanni, J.M., D.J. Stephens, S.T. Miller, L.K. Weimer, G. Graff, D. Parnell, J.M. Spellman, M.T. Brady, and D.A. Gamache. 1996. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. J Ocul Pharmacol Ther 12:389.
5. Maling, H.M., M.E. Webster, M.A. Williams, W. Saul, and W. Anderson. 1974. Inflammation induced by histamine, serotonin, bradykinin and compound 48/80 in the rat: Antagonists and mechanisms of action. J Pharmacol Exp Ther 191:300.
6. Rowley, D., and E. Benditt. 1956. 5-Hydroxytryptamine and histamince as mediators of the vascular injury produced by agents which damage mast cells in rats. J Exp Med 103:399.
7. Yanni, J.M., L.K. Weimer, R.L. Glaser, L.S. Lang, S.M. Robertson, and J.M. Spellman. 1993. Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats. Int Arch Allergy Immunol. 101:102.
8. Nonaka, H., A. Ishii, and H. Kase. 1993. Effect of KW-4679, a novel antiallergic agent, on histamine H1 receptor. Jpn. J. Pharmacol. 61:87.
9. Nonaka, H., S. Otaki, E. Ohshima, M. Kono, H. Kase, K. Ohta, H. Fukui, and M. Ichimura. 1998. Unique binding pocket for KW-4679 in the histamine H1 receptor. European Journal of Pharmacology 345:111.
10. Sharif, N.A., M.R. Hellberg, J.M. Yanni. 1997. Antihistamines, topical ocular. In Burger's Medicinal Chemistry and Drug Discovery, Volume 5: Therapeutic Agents. M.E. Wolf, ed. John Wiley & Sons, Inc., New York, pp. 255.